North America’s medical devices industry saw a rise of 25.00% in cross border deal activity during March 2021, when compared with the last 12-month average, led by Organon &’s $240m acquisition of Alydia Health, according to GlobalData’s deals database.
- Embed this chart
Embed this chart into your website
Copy and paste the image source into your website to display the chart.
A total of 20 medical devices industry cross border deals worth $919.51m were announced for the region in March 2021, against the 12-month average of 16 deals.
Of all the deal types, venture financing saw most activity in March 2021 with ten transactions, representing a 50% share for the region.
In second place was M&A with eight deals, followed by private equity deals with two transactions, respectively capturing a 40% and 10% share of the overall cross border deal activity for the month.
In terms of value of cross border deals, M&A was the leading category in North America’s medical devices industry with $488m, while venture financing and private equity deals totalled $310.51m and $121m, respectively.
North America medical devices industry cross border deals in March 2021: Top deals
The top five medical devices cross border deals accounted for 63.4% of the overall value during March 2021.
The combined value of the top five medical devices cross border deals stood at $583m, against the overall value of $919.51m recorded for the month.
The top five medical devices industry cross border deals of March 2021 tracked by GlobalData were:
1) Organon &’s $240m acquisition of Alydia Health
2) The $110m acquisition deal with 7D Surgical by SeaSpine
3) Alumni Ventures Group, aMoon Partners, Echo Health Ventures, Khosla Ventures and Northpond Ventures’ $82m venture financing of Scipher Medicine
4) The $81m private equity deal with Rapid Micro Biosystems by Adage Capital Management, Ally Bridge Group, Asahi Kasei Medical, Bain Capital Life Sciences, BlackRock, CaaS Capital Management, D1 Capital Partners, Endeavour Vision, Longitude Capital Management Co, Quaker Partners Management, Sunley House Capital Management, T Rowe Price Associates and Xeraya Capital Sdn
5) TELUS Health Solutions’ asset transaction with Babylon Healthcare Services for $70m.
Verdict deals analysis methodology
This analysis considers only announced and completed cross border deals from the GlobalData financial deals database and excludes all terminated and rumoured deals. Country and industry are defined according to the headquarters and dominant industry of the target firm. The term ‘acquisition’ refers to both completed deals and those in the bidding stage.
GlobalData tracks real-time data concerning all merger and acquisition, private equity/venture capital and asset transaction activity around the world from thousands of company websites and other reliable sources.
More in-depth reports and analysis on all reported deals are available for subscribers to GlobalData’s deals database.